Imaging for prevention

Area of Science:

• Cardiology
• Public Health
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) remains a leading global cause of death and illness.
• Despite a 35% reduction in CVD deaths over two decades, a significant detection gap persists.
• Approximately 840,000 deaths are attributed to CVD annually in the US, exceeding cancer deaths by 300,000.

Purpose of the Study:

• To evaluate the persistent detection gap in cardiovascular disease (CVD).
• To assess the potential benefits of screening for identifying high-risk patients.
• To address the question of whether CVD screening is warranted for asymptomatic individuals.

Main Methods:

• Analysis of recent cardiovascular disease (CVD) mortality statistics.
• Review of trends in CVD death reductions over the past two decades.
• Examination of the proportion of CVD deaths in previously asymptomatic individuals.

Main Results:

• Cardiovascular disease (CVD) deaths have declined by over 35% in the last 20 years.
• A substantial detection gap in cardiovascular disease (CVD) management remains.
• Three-quarters of cardiovascular disease (CVD) deaths occurred in individuals without prior symptoms.

Conclusions:

• Cardiovascular disease (CVD) continues to be a major global health concern.
• The high incidence of CVD in asymptomatic individuals suggests a need for improved detection strategies.
• Screening for cardiovascular disease (CVD) warrants consideration for early identification of at-risk patients.